TEVIMBRA

What is this medication? Tevimbra is a prescription immunotherapy medication used to treat adults with a specific type of cancer called esophageal squamous cell carcinoma. It is specifically indicated for patients whose cancer cannot be removed by surgery or has spread to other parts of the body after they have already received prior systemic chemotherapy. This medication is typically administered as an intravenous infusion by a healthcare professional in a clinical setting.

The active ingredient in Tevimbra is tislelizumab-jsgr, which belongs to a class of drugs known as programmed death receptor-1 blocking antibodies. It works by binding to the PD-1 receptor on the surface of immune cells called T-cells. By blocking this specific pathway, the medication helps the immune system recognize and attack cancer cells more effectively, which can help slow the progression of the disease or shrink existing tumors.